Response to letter commenting on 'indications for hyperthermic intraperitoneal chemotherapy (Hipec) with cytoreductive surgery: a systematic review'
- PMID: 32900560
- DOI: 10.1016/j.ejca.2020.07.013
Response to letter commenting on 'indications for hyperthermic intraperitoneal chemotherapy (Hipec) with cytoreductive surgery: a systematic review'
Conflict of interest statement
Conflict of interest statement The authors declare no conflicts of interest.
Comment on
-
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.Eur J Cancer. 2020 Mar;127:76-95. doi: 10.1016/j.ejca.2019.10.034. Epub 2020 Jan 24. Eur J Cancer. 2020. PMID: 31986452
-
Letter comments on 'Indications for hyperthermic intraperitoneal chemotherapy (Hipec) with cytoreductive surgery: a systematic review'.Eur J Cancer. 2020 Nov;139:190-191. doi: 10.1016/j.ejca.2020.06.038. Epub 2020 Aug 15. Eur J Cancer. 2020. PMID: 32811687 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
